Nicholas Robert, MD: The FDA and Education on Biosimilars

October 14, 2019

Nicholas Robert, MD, medical director of data, evidence and insights at McKesson Life Sciences, discusses the FDA’s role in helping providers become comfortable with biosimilars.

Transcript

Yes, I think regulatory agencies have a real leadership role to play. They’re, you know, the referee. The government, the FDA, is here to serve the citizens and support effective and safe care. And there is also a role in affordable care, so providing some guidance in terms of efficacy and safety will help pave the way to affordable care. So the FDA has also changed; I think they’re much more responsive to what’s happening. I think they’re a key partner and playing a significant role as we improve care.